Gene amplification in the premalignant stages of non-small cell lung cancer development - Top-Institutions - MDSpire

Gene amplification in the premalignant stages of non-small cell lung cancer development

  • By

  • Vanessa G. P. Souza

  • Katya H. Bénard

  • Greg L. Stewart

  • Katey S. S. Enfield

  • William W. Lockwood

  • Wan L. Lam

  • May 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #3

    Lung Cancer Mutation Consortium
    Lung Cancer Mutation Consortium

    N/A, N/A

    Key Differentiators

    • Oncology

  • #4

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology

  • #5

    Washington University School of Medicine
    Washington University School of Medicine

    St. Louis, Missouri

    Key Differentiators

    • Oncology

Original Source(s)

Gene amplification in the premalignant stages of non-small cell lung cancer development

  • by Vanessa G. P. Souza, Katya H. Bénard, Greg L. Stewart, Katey S. S. Enfield, William W. Lockwood, Wan L. Lam

  • May 20, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer